Health
Moffitt researchers discover mechanism that regulates anti-tumor activity of immune cells – EurekAlert
In a new article published in Nature, Moffitt Cancer Center researchers demonstrate why some ovarian cancer patients evolve better than others and suggest possible…
TAMPA, Fla. — The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed. These poor outcomes are partly due to the lack of effective therapies for advanced disease and recurrence. Immunotherapies hold promise for many types of cancer; however, studies have shown that patients with ovarian cancer do not have strong responses to existing drugs. In a new article published in Nature, Moffitt…
-
Business24 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General20 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News23 hours agoNew FLC President has regional lens – Proctor
-
Noosa News19 hours agoCCTV footage shows stolen ute slamming into fuel bowsers at Kojonup petrol station